Navidea Biopharmaceuticals, INC.
At a glance
Employees1-19
In business sinceNot reported
HeadquartersColumbus, OH
US patents14
SAM.gov UEIGQWFJQX2UKJ2
CAGE code085F3
Incorporated inDE
LEI549300HXUMV6VNCPEE05
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
14 US patents granted 2012–2025, 10 of them in the five years to SEP 2025.
Pharmaceuticals 12Measurement 1Organic fine chemistry 1
- Amide linkages of sugar moieties to amine terminated leashes attached to carbohydrate polymersUS 12,404,349 · granted SEP 2, 2025
- CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linkerUS 12,297,222 · granted MAY 13, 2025
- Altering net charge on mannosylated dextrans to maximize target tissue uptake and off target competitive blockingUS 12,178,829 · granted DEC 31, 2024
- CD206 targeted drug delivery vehicles carrying novel bisphosphonate drug payloads via a degradable linkerUS 12,006,339 · granted JUN 11, 2024
- Compounds and methods for diagnosis and treatment of viral infectionsUS 12,005,122 · granted JUN 11, 2024
Newest 5 shown · Granted to Navidea Biopharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Navidea Biopharmaceuticals, INC. | Columbus | OH | 1–19 | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.
